CIK 0000898437 · Accelerated filer
Anika Therapeutics, Inc.
Sign in to watch- Ticker
- ANIK
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043145961
- Phone
- (781) 457-9000
- Business address
- 32 WIGGINS AVENUE, BEDFORD, MA, 01730
- Former names
- ANIKA THERAPEUTICS INC, ANIKA RESEARCH INC
- 4 Open-market buy President and CEO bought 12,200 shares at $12.29 ($149,881)
- 10-Q Report Quarterly Report
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Results of operations · Executive or director change
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes EVP, General Counsel, Corp Sec gave up 6,061 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 5,944 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 26,832 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, CAO & Treasurer gave up 2,230 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, General Counsel, Corp Sec gave up 1,919 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 5,871 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, CAO & Treasurer gave up 639 shares (to pay taxes)
- 10-K Report Annual Report
- 8-K Event Results of operations · Executive or director change
- 4 Derivatives Options or other derivatives
- SCHEDULE 13D/A Stake Beneficial Ownership Report
Page 2 of 55 · 1,098 filings